SyntheticMR AB (publ) Stock: price and insider trades · Sweden

Every trade that managers of SyntheticMR AB (publ) disclose to Finansinspektionen is tracked on this page. The company sits in the Health Care sector. From 18 October 2025 to 18 October 2026, the disclosure feed for SyntheticMR AB (publ) logged 2 filings by 2 insiders.

Only purchases show up on the open market, 1 purchase in all worth €38k, filed by 1 insider. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Among those who bought: 1 chief executive. At €38k, the purchase published on 17 February 2026 by Lena Åredal is the largest of the period (0.81% of market cap).

The data flag 1 purchase as part of a group of insiders buying within 30 days of each other. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase. The most recent open-market purchase was published on 17 February 2026, 243 days ago.

Across the 890 companies tracked on its exchange, the median is 7 filings; at 2 filings, this issuer sits below that mark. Looking back to 2026, when coverage begins, insiders filed 1 purchase and no sales.

Elsewhere in the same sector, our signals recently picked up insider purchases at Anixa Biosciences Inc and Vivos Inc. These figures are compiled from regulatory filings published by Finansinspektionen. They describe what insiders did and are not a recommendation.